Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ben-Horin

Showing results (241-250 of 362) with videos related to

Pageof 37
Sort By:
Frontiers in Immunology|January 11, 2020
Molecular Landscape of Anti-Drug Antibodies Reveals the Mechanism of the Immune Response Following Treatment With TNFα AntagonistsAnna Vaisman-Mentesh, Shai Rosenstein, Miri Yavzori, et al.
United European Gastroenterology Journal|August 7, 2025
Elderly-Onset Inflammatory Bowel Disease Has Distinct Disease Characteristics and Treatment PatternsMaya Granot, Uri Kopylov, Yael Talmor, et al.
Inflammatory Bowel Diseases|June 16, 2011
Practice of gastroenterologists in treating flaring inflammatory bowel disease patients with clostridium difficile: antibiotics alone or combined antibiotics/immunomodulators?Henit Yanai, Geoffrey C Nguyen, Laura Yun, et al.
Alimentary Pharmacology & Therapeutics|November 11, 2017
Early drug and anti-infliximab antibody levels for prediction of primary nonresponse to infliximab therapyH Bar-Yoseph, N Levhar, L Selinger, et al.
Inflammatory Bowel Diseases|June 24, 2017
Serum Interleukin 9 Levels Predict Disease Severity and the Clinical Efficacy of Infliximab in Patients with Crohn's DiseaseTing Feng, Baili Chen, Li Li, et al.
The Israel Medical Association Journal : IMAJ|August 14, 2023
Jejunal Inflammation in Crohn's Disease: Comparison between Diffusion Weighted Magnetic Resonance Imaging and Video Capsule EndoscopyMichal M Amitai, Nadin Kanaan, Shelly Soffer, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 20, 2013
Dose optimization is effective in ulcerative colitis patients losing response to infliximab: a collaborative multicentre retrospective studyMonica Cesarini, Konstantinos Katsanos, Konstantinos Papamichael, et al.
World Journal of Gastroenterology|February 17, 2015
Significance of low level infliximab in the absence of anti-infliximab antibodiesBella Ungar, Adi Anafy, Henit Yanai, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 18, 2017
Diagnostic yield of capsule endoscopy versus magnetic resonance enterography and small bowel contrast ultrasound in the evaluation of small bowel Crohn's disease: Systematic review and meta-analysisUri Kopylov, Diana E Yung, Tal Engel, et al.
Frontiers in Medicine|September 13, 2021
A Convolutional Neural Network Deep Learning Model Trained on CD Ulcers Images Accurately Identifies NSAID UlcersEyal Klang, Uri Kopylov, Brynjulf Mortensen, et al.
Pageof 37

Showing results (241-250 of 362) with videos related to

Sort By:
Pageof 37
Frontiers in Immunology|January 11, 2020
Molecular Landscape of Anti-Drug Antibodies Reveals the Mechanism of the Immune Response Following Treatment With TNFα AntagonistsAnna Vaisman-Mentesh, Shai Rosenstein, Miri Yavzori, et al.
United European Gastroenterology Journal|August 7, 2025
Elderly-Onset Inflammatory Bowel Disease Has Distinct Disease Characteristics and Treatment PatternsMaya Granot, Uri Kopylov, Yael Talmor, et al.
Inflammatory Bowel Diseases|June 16, 2011
Practice of gastroenterologists in treating flaring inflammatory bowel disease patients with clostridium difficile: antibiotics alone or combined antibiotics/immunomodulators?Henit Yanai, Geoffrey C Nguyen, Laura Yun, et al.
Alimentary Pharmacology & Therapeutics|November 11, 2017
Early drug and anti-infliximab antibody levels for prediction of primary nonresponse to infliximab therapyH Bar-Yoseph, N Levhar, L Selinger, et al.
Inflammatory Bowel Diseases|June 24, 2017
Serum Interleukin 9 Levels Predict Disease Severity and the Clinical Efficacy of Infliximab in Patients with Crohn's DiseaseTing Feng, Baili Chen, Li Li, et al.
The Israel Medical Association Journal : IMAJ|August 14, 2023
Jejunal Inflammation in Crohn's Disease: Comparison between Diffusion Weighted Magnetic Resonance Imaging and Video Capsule EndoscopyMichal M Amitai, Nadin Kanaan, Shelly Soffer, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 20, 2013
Dose optimization is effective in ulcerative colitis patients losing response to infliximab: a collaborative multicentre retrospective studyMonica Cesarini, Konstantinos Katsanos, Konstantinos Papamichael, et al.
World Journal of Gastroenterology|February 17, 2015
Significance of low level infliximab in the absence of anti-infliximab antibodiesBella Ungar, Adi Anafy, Henit Yanai, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 18, 2017
Diagnostic yield of capsule endoscopy versus magnetic resonance enterography and small bowel contrast ultrasound in the evaluation of small bowel Crohn's disease: Systematic review and meta-analysisUri Kopylov, Diana E Yung, Tal Engel, et al.
Frontiers in Medicine|September 13, 2021
A Convolutional Neural Network Deep Learning Model Trained on CD Ulcers Images Accurately Identifies NSAID UlcersEyal Klang, Uri Kopylov, Brynjulf Mortensen, et al.
Pageof 37